UL Solutions ( NYSE : ULS ) & Applied DNA Sciences ( NASDAQ : APDN ) Critical Review

Applied DNA Sciences (APDN) and UL Solutions (ULS) are both industrial products companies, but their performance varies across several key metrics. Valuation & Earnings: UL Solutions has higher revenue ($2.68 billion) and earnings ($260.00 million) compared to Applied DNA Sciences ($13.37 million in revenue and -$9.95 million in net income). The price/sales ratio for UL Solutions is 3.65, while Applied DNA Sciences has a ratio of 1.05. Institutional and Insider Ownership: Applied DNA Sciences has 22.2% of its shares held by institutional investors and 1.0% by company insiders. UL Solutions data is not available. Analyst Recommendations: Applied DNA Sciences has a consensus price target of $1.50, suggesting a potential upside of 9.49%. UL Solutions has a consensus price target of $43.90, indicating a potential downside of 10.11%. Research analysts favor Applied DNA Sciences over UL Solutions based on these ratings. Profitability: Applied DNA Sciences has a net margin of -214.42%, return on equity of -138.41%, and return on assets of -58.97%. UL Solutions data is not available. In summary, UL Solutions outperforms Applied DNA Sciences in terms of revenue and earnings. However, Applied DNA Sciences has stronger institutional ownership and analyst recommendations, indicating a more favorable outlook. Profitability data for UL Solutions is not available. Overall, the superior business depends on the investor s priorities, with UL Solutions excelling in financial metrics and Applied DNA Sciences showing potential for growth and analyst support.

Source: modernreaders.com
Published on 2024-09-15